anti-CD20 CAR T-cell therapy (allogeneic placental cells, non-Hodgkin's lymphoma)

No patents found under this name

Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.